Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News
LucidSearch
QuickAnswers

Contact Us

Search

ZEVASKYN

Cell_Gene_Therapy

Cell and Gene Therapy Today—December 11, 2025

This week’s Cell & Gene Therapy update highlights two major FDA approvals…

Immunology

Immunology Today—December 10, 2025

This week’s Immunology update highlights key advances in gene therapy,…

Rare Disease news

Rare Diseases Weekly News - May 1st 2025

This Week in Rare Disease Breakthroughs 🧬 | Pivotal Approvals, New Orphan Drug…

by Timos Papagatsias

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Lucid Diligence Brief: Pfizer YaoPharma oral GLP-1 deal
Vaccines Video Recap—December 12, 2025
Vaccines Today—December 12, 2025
Respiratory Video Recap—December 12, 2025
Respiratory Today—December 12, 2025

Tags

AAAAI 2025 advanced therapies american college of cardiology Anti-Vaccine Movement Asundexian Atogepant BIA bioinformatics brain tumors cancer ckd climate change and health Clinical immunology Congenital aceruloplasminemia corporate venture capital drug pricing drug supply chain Elranatamab Enveda ESMO 2021 facial rejuvenation gene editing gene therapy approval gi oncology Helicobacter pylori hematology Influenza A investment managed entry agreements Mismatch repair deficiency nanotechnology NFTs in healthcare non viral vectors oncology trials OSE Immunotherapeutics pharma pneumonia radiation oncology Recurrent respiratory papillomatosis remote patient monitoring Sema4 SKYRIZI tissue engineering Toripalimab unconventional trial designs

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: Pfizer YaoPharma oral GLP-1 deal
Vaccines Video Recap—December 12, 2025
Vaccines Today—December 12, 2025
Respiratory Video Recap—December 12, 2025
Respiratory Today—December 12, 2025

TAGS

AAAAI 2025 advanced therapies american college of cardiology Anti-Vaccine Movement Asundexian Atogepant BIA bioinformatics brain tumors cancer ckd climate change and health Clinical immunology Congenital aceruloplasminemia corporate venture capital drug pricing drug supply chain Elranatamab Enveda ESMO 2021 facial rejuvenation gene editing gene therapy approval gi oncology Helicobacter pylori hematology Influenza A investment managed entry agreements Mismatch repair deficiency nanotechnology NFTs in healthcare non viral vectors oncology trials OSE Immunotherapeutics pharma pneumonia radiation oncology Recurrent respiratory papillomatosis remote patient monitoring Sema4 SKYRIZI tissue engineering Toripalimab unconventional trial designs

Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News
LucidSearch
QuickAnswers

© 2025 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy